Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
Eli Lilly’s $3.2 Billion Acquisition of Morphic Holdings
Bristol Myers Squibb’s $13 Billion Bond Offering
Kirkland & Ellis advised Bristol Myers Squibb on the offering, and Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters. Bristol...
AlloVir’s $75 Million Common Stock Public Offering
Goodwin Procter represented AlloVir, and Latham & Watkins represented the underwriters in the offering. AlloVir, Inc. (Nasdaq: ALVR) announced the pricing of an underwritten public offering...
The Duckhorn Portfolio’s $92.1 Million Secondary Offering
Ropes & Gray is advising The Duckhorn Portfolio, and Latham & Watkins is advising the underwriter involved in the offering. The Duckhorn Portfolio, Inc. (NYSE: NAPA)...
Iris Energy’s $231.5 Million Initial Public Offering
Latham & Watkins represented Iris Energy, while Davis Polk advised the representatives of the several underwriters in the IPO. Clifford Chance advised Australian company Iris Energy...
Vacasa’s $4.5 Billion De-SPAC Business Combination with TPG Pace Solutions
Latham & Watkins LLP represented Vacasa in the transaction, while Weil, Gotshal & Manges advised TPG Pace Solutions. Vacasa, the leading vacation rental management platform in...
Vontier’s $1.6 Billion Notes Offering
Davis Polk advised the initial purchasers in the offering. Vontier Corporation executed the offering of $500 million aggregate principal amount of its 1.800% notes due 2026, $500...
Kennametal’s $300 Million Notes Offering
Davis Polk advised the joint book-running managers on the offering. Kennametal Inc. executed its offering of $300 million aggregate principal amount of 2.800% senior notes due 2031. ...